Page 27 - Towards personalized therapy for metastatic prostate cancer: technical validation of [18F]fluoromethylcholine
P. 27
chapter 2
Dual-phase PET/CT to dif ferentiate [18F]fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer
Daniela E. Oprea-Lager1 Andrew D. Vincent2 Reindert J.A. van Moorselaar3 Winald R. Gerritsen4,5 Alfons J.M. van den Eertwegh5 Jonas Eriksson1,6 Ronald Boellaard1 Otto S. Hoekstra1
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands 2Department of Biometrics, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands 3Department of Urology, VU University Medical Center, Amsterdam, the Netherlands 4 Department of Oncology, St Radboud University Medical Center, Nijmegen, the Netherlands 5Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands 6 Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, Uppsala University, P.O. Box 256, SE-751 05 Uppsala, Sweden
PLoS One. 2012;7(10):e48430
